TipRanks
Go Ultimate55% OFF

Gregg Alton Insider Profile

11 Followers

Gregg Alton, Director at Novavax, holds 47.69K shares in Novavax (Ticker: NVAX), holds ― shares in Corcept Therapeutics (Ticker: CORT), holds 58.05K shares in Gilead Sciences (Ticker: GILD).

Gregg Alton's Trading History

NVAX
Novavax
Jun 23, 2026DirectorUninformative Buy172.37K$480.66K
GILD
Gilead Sciences
Mar 05, 2019Chief Patient OfficerUninformative Buy18.96K$9.91M
SNOA
Sonoma Pharmaceuticals
―Director―$0.00
EIGRQ
Eiger Biopharmaceuticals
―――$0.00
LNAI
Lunai Bioworks
―Director――
CORT
Corcept Therapeutics
―Director――

You May Also Like

Gregg Alton insider profile FAQ

What is the percentage of profitable transactions made by Gregg Alton?
The percentage of profitable transactions made by Gregg Alton is 65%.
What is the average return per transaction made by Gregg Alton?
The average return per transaction made by Gregg Alton is 2.60%.
What stocks does Gregg Alton hold?
Gregg Alton holds: NVAX, CORT, GILD, LNAI, EIGRQ, SNOA stocks.
What was Gregg Alton’s latest transaction?
Gregg Alton’s latest transaction was an Uninformative Buy of $172.37K.
What was Gregg Alton's most profitable transaction?
Gregg Alton’s most profitable transaction was an Informative Sell of GILD stock on April 21, 2016. The return on the trade was 33.50%.
What is Gregg Alton's role in Novavax?
Gregg Alton's role in Novavax is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.